Clinical Trial

Glymphatic Function TMS Study

Study acronym: GF-TMS
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to use transcranial magnetic stimulation (TMS) in older adults to impact the glymphatic system. The glymphatic system is a brain-wide clearance pathway that plays a crucial role in removing dysfunctional proteins in Alzheimer's disease. This project aims to investigate if TMS can help glymphatic function and reduce levels of these proteins in those with mild cognitive impairment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-24.
Trial Details
NCT Number NCT07192913
Lead Sponsor University of Arizona
Conditions Mild Cognitive Impairment
Enrollment 20 participants
Start Date 2026-01
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-17